Calcium + Company is launching an oncology marketing division, Amino, the company announced Wednesday.
Amino will aim to provide clients with a marketing approach supported by the agency’s expertise in oncologic science, strategy and creative services.
Josh Righter is slated to head Amino as associate managing director and will report to Calcium + Company group president Greg Lewis. Righter previously served as SVP and creative director at Calcium, a 2022 MM+M Agency 100 honoree, before moving to Evoke as SVP and group creative director in 2021.
The debut of Amino comes shortly after Calcium launched Calcium + Company, with the goal of unifying its various divisions under one umbrella. With that emerged PRotein, a health and wellness PR division that will provide “strategic consultative services, integrated storytelling and audience engagements” and be helmed by industry veteran Stacey Gandler.
“Amino represents an extension of our ‘brand nourishment’ DNA into the world of oncology,” Lewis said in a statement. “With the addition of Josh’s leadership to a passionate team, I’m excited to see the stories we’ll help to tell in this critically important category.”
One year ago, Calcium also launched the medical communication division Vitamin MD, led by Brad Quosig and Lauren Lazar.
Amino’s leadership team will also include Chris Watson and Tim Wisniewski. Righter, who previously helped build Calcium’s oncology expertise, will be returning to the company from his position at Evoke.
“Today, oncology brands and companies must rise above the noise with a fully integrated, bespoke approach – one that creates strong and durable bonds with HCPs, patients, care partners and communities,” Righter said in a statement. “With Amino, I’m so excited to return to the Calcium family to be part of this team of experienced storytellers – one that has honed a unique methodology by fusing scientific pedigree with unmatched oncology marketing expertise.”
According to MM+M’s Agency 100 2022 revenue chart, Calcium’s revenue grew 38%, from $35.9 million in 2020 to $46 million in 2021. Staff size also increased from 130 in 2020 to 139 at the end of 2021.In late 2021, Calcium announced it had secured funding through a partnership with private equity firm NexPhase Capital. “We can do what we’ve always done, which is invest in ourselves and our people, but on such a bigger level,” Calcium founder and chairman Steven Michaelsontold MM+M at the time.